SPOTLIGHT -
Slideshow
Author(s):
Which of these agents best prevents relapse? A recent study employed a novel approach to find out.
Discontinuing Antipsychotics
Here's to a Psychedelic Revolution
LB-102 for Schizophrenia Sees Positive Phase 2 Topline Results
Treating ‘Morally Objectionable’ Patients
Alto Neuroscience Presents Key Data, Study Findings on ALTO-300
Where do Psychedelics Fit in the Future of Psychiatry?